Press Release: Corium : Corium's Novel ADHD Medication AZSTARYS (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth Rate
New analysis from long-term study published in Journal of Child and Adolescent Psychopharmacology Reinforces prior data demonstrating AZSTARYS, first...
Read full article »
Corium is a Michigan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of central nervous system disorders.
Read more